MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

Dogster.com Teams With Morris Animal Foundation to Cure Canine Cancer, While Helping Dogs Suffering From Cancer Today - Makes US$2 Donation for Each Subscription

- One in Four Dogs Dies of Cancer

- The Number One Cause of Death in Dogs Over the Age of Two

— DENVER, August 13

DENVER, August 13 /PRNewswire/ -- Dogster.com, the world's most popular and comprehensive Web site devoted to the health and happiness of dogs, has joined Morris Animal Foundation (MAF) in its global effort to find a cure for canine cancer. Dogster will donate US$2 for every new subscription or subscription extension, through September 30. To subscribe go to http://www.dogster.com, scroll down on the home page to "site updates" and the help cure canine cancer link. By subscribing, dog lovers will get access to tons of insightful and inspiring dog-centric content and directly help save their dog's life.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040701/LAMAFLOGO)

"Canine cancer is an issue our members feel really passionate about. MAF is doing great work and we are really happy to help their cause," said Steven Reading co-founder of Dogster.com.

MAF is undertaking an unprecedented campaign to fund research to cure canine cancer, in the lifetime of a dog -- the next 10 to 20 years. MAF-funded research will also help develop treatments to aid dogs suffering today. All dogs face a grave threat from cancer. One in four dogs dies of cancer -- even higher for golden retrievers where 60 percent will die of cancer. It is the number-one cause of death in dogs over the age of two. Many more dogs suffer the devastating effects of the disease. Visit MAF's dedicated canine cancer Web site at http://www.CureCanineCancer.org and watch the canine cancer Web exclusive that includes information from some of the world's top canine oncologists.

About Morris Animal Foundation:

Morris Animal Foundation, established in 1948, is dedicated to funding animal health research that protects, treats and cures companion animals and wildlife. MAF has been at the forefront of funding breakthrough research studies benefiting animals in some 100 countries, spanning all seven continents. MAF has its headquarters in Denver. The Foundation has funded more than 1,500 humane animal health studies. Charity Navigator ranks MAF as a four-star charity, the highest rating. For more information, call +1-800-243-2345, or visit http://www.MorrisAnimalFoundation.org.

Web site: http://www.morrisanimalfoundation.org http://www.CureCanineCancer.org

Related news

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us